Profile: Angioscore, Inc. offers balloon catheters for treating both peripheral arterial disease (PAD) and coronary artery disease (CAD). The innovative nitinol scoring element in our products scores the plaque circumferentially, providing a precise and predictable dilatation across a wide range of lesion types. Our AngioSculpt® PTA Scoring Balloon Catheter significantly alters the landscape for treating PAD. This catheter has been proven effective in complex calcified lesions (67.4%), bifurcation (25.6%), and ostial (15.1%) lesions. It has a record of significantly low dissection rate and successful deployment in 98.8% of lesions. Semi-compliant balloon material allows the physician to tailor the device size to the vessel (2-20 atm) depending on the size of the balloon. Nitinol-enhanced balloon deflation offers excellent rewrap and recross capabilities. AngioSculpt® PTCA Scoring Balloon Catheter is used for treating CAD. It treats complex lesions, including in-stent restenosis (ISR) and type C lesions. It offers freedom from major adverse cardiac events. This is the only coronary balloon catheter with specific indication for treating type C lesions.
The company was founded in 2003 and is CE certified.
FDA Registration Number: 3005462046
5 Products/Services (Click for related suppliers)
|• Angiographic Balloon Catheter|
|• Balloon Catheters|
|• Cutting/Scoring Percutaneous Transluminal Coronary Angioplasty (Ptca) Catheter (FDA Code: NWX)|
|• Percutaneous Catheter (FDA Code: DQY / 870.1250)|
|• Peripheral Transluminal Angioplasty Catheter (FDA Code: LIT / 870.1250)|